NephLong
Darbesis
Details
25 mcg
40 mcg
60 mcg
Generic Name: Darbepoetin Alfa
Product Description:
Darbesis Injection contains Darbepoetin Alfa, a synthetic erythropoiesis-stimulating agent (ESA). It is used to stimulate red blood cell production and is structurally modified for an extended half-life compared to erythropoietin.
Strengths Available: Commonly available in multiple strengths such as 25 mcg, 40 mcg, 60 mcg, 100 mcg, 200 mcg per prefilled syringe or vial, depending on the market.
Indications:
-
Treatment of anemia associated with chronic kidney disease (CKD), both in dialysis and non-dialysis patients.
-
Treatment of anemia in cancer patients receiving chemotherapy.
Dosage Form:
Injection (prefilled syringe or single-dose vial), for subcutaneous or intravenous administration.
Key Features:
-
Long-acting erythropoiesis-stimulating agent.
-
Reduces the need for frequent dosing compared to epoetin alfa.
-
Helps improve hemoglobin levels and reduce symptoms of anemia.
Storage:
Store at 2°C to 8°C. Do not freeze. Protect from light.
Keto Nephron™ DS is a Medical Food as defined under 21 U.S.C. §360ee(b)(3) and 21 CFR 101.9(j)(8), formulated for the dietary management of Chronic Kidney Disease (CKD) Stages 3-5 in adults following physician-supervised protein-restricted diets. It is not a drug, not a dietary supplement, and is not intended for self-medication or general wellness use. MUST BE USED UNDER MEDICAL SUPERVISION. Quantum LifeSciences Inc., Claremont, CA 91711, USA. FDA Food Facility (Manufacturer) Reg. No. 14961463490.